admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion...

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use...

Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Psychedelic Research Bulletin: February2023

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual...

Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy...

Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Psychedelics Weekly – More Trouble For Field Trip Health, Ketamine Wellness...

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial...

Psyence Group Announces Cantheon Capital Private Placement

1...767778...218 Page 77 of 218

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin